Edit

Cordis

http://www.cordis.com/affiliates-directory

Last activity: 07.11.2023

Tags:HardwareMedTech

A medical device company with a portfolio of cardiovascular and endovascular devices

Mentions

Location: United States, California, Santa Clara

Employees: 1001-5000

Founded date: 1957

Investors 2

Date	Name	Website
-	Easton Cap...	eastoncapi...
07.06.2022	Kohlberg K...	kkr.com

Mentions in press and media 22

Date	Title	Description	Source
07.11.2023	Cordis has a new CEO	Cordis CEO Scott Drake [Photo courtesy of Cordis]About two months after former Spectranetics CEO Sco...	massdevice...
27.10.2023	CMS changes coverage policy for carotid stenting to make it ...	Dave Fornell \| October 18, 2023 \| Cardiovascular Business \| Interventional Cardiology A group of in...	tidewateri...
05.09.2023	Cordis names former Spectranetics CEO as executive chair	Scott Drake is the new executive chair of Cordis’ board of directors [Image courtesy of Cordis]Inter...	massdevice...
20.10.2022	Cordis To Acquire MedAlliance, For Up To $1.135 Billion	MedAlliance to be Acquired by Cordis36 Cordis, a Miami, FL-based provider of a development and manu...	finsmes.co...
08.07.2022	CORDIS NAMES BRYAN LOO PRESIDENT OF ASIA-PACIFIC REGION	Seasoned medical technology leader tapped to maximize momentum in APAC MIAMI LAKES, Fla., July 8, 2...	en.prnasia...
12.03.2021	Cardinal Health Signs Definitive Agreement to Sell its Cordi...	March 12th, 2021 DUBLIN, Ohio Cardinal Health (NYSE: CAH) today announced that it has signed a def...	hf.com/car...
29.05.2015	Johnson and Johnson accepts $2B offer for vascular medical d...	Otsuka Pharmaceutical Co Ltd lost a lawsuit challenging the U.S. Food and Drug Administration’s deci...	medcitynew...
10.09.2014	Press Release: Cordis Corporation launches INCRAFT AAA stent...	FREMONT, CA – Cordis Corporation announced today the launch of its INCRAFT AAA Stent Graft System (I...	massdevice...
12.03.2013	Cordis Acquires Flexible Stenting Solutions, a Biomark Capit...	Agreement Expands Treatment Options for Advanced Peripheral Artery Disease Bridgewater, NJ – March ...	biomarkcap...
28.06.2012	Stent development company initiating clinical trial raises $...	Svelte is conducting a 30-patient clinical trial of its drug-eluting stent in New Zealand, a favorit...	medcitynew...
16.12.2011	Fischell stent development co. raises $17 million in series ...	Pomeranz said the New Providence, New Jersey company’s Acrobat stent is the first advancement in del...	medcitynew...
07.09.2011	AtriCure: Is now the time for a strategic acquirer to step u...	“We’re coming upon a time in which AtriCure’s strategic value will increase over the next 12 to 18 m...	medcitynew...
11.08.2010	SPARQLZ Shines as a Vision for Linked Data Made Easy	SPARQLZ is a stealth technology project aimed to provide a graphical user interface for everyday use...	readwrite....
06.08.2010	Cordis wins again on appeal in ‘heated’ fight over Cypher st...	Cordis does not use any heat to bond metal to polymer in its Cypher stents and that’s more than cool...	massdevice...
05.05.2010	Cleveland Clinic comes clean on cardiologist	By Mary Vanac The Cleveland Clinic admitted that a former staff physician and inventor, Dr. Jay Yad...	massdevice...
19.02.2010	Johnson & Johnson appeals patent ruling	Johnson & Johnson (NYSE:JNJ) appealed a federal judge’s ruling that four of its Cordis Corp. sub...	massdevice...
21.01.2010	Federal judge: Four J&J patents invalid in infringement ...	Boston Scientific Corp. (NYSE:BSX) won the latest round in its long-running patent war with Johnson ...	massdevice...
29.11.2006	Impedance Cardiology raises $5 million	Impedance Cardiology Systems Inc., a Menlo Park, Calif.-based biotech startup, has raised $5 million...	venturebea...
-	AtriCure: Is now the time for a strategic acquirer to step u...	Medical device giants looking to boost their atrial fibrillation product portfolios would do well to...	medcitynew...
-	Fischell stent development co. raises $17 million in series ...	Svelte Medical Systems, a medical device company started by serial entrepreneurs Robert Fischell and...	medcitynew...
-	Johnson and Johnson accepts $2B offer for vascular medical d...	TOP STORIES Johnson & Johnson (NYSE: JNJ) has accepted Cardinal Health‘s $2 billion offer to ac...	medcitynew...
-	Stent development company initiating clinical trial raises $...	A stent development company founded by serial entrepreneurs Robert Fischell and his sons David and T...	medcitynew...